Accolade, Inc. ( ACCD) - Key Metrics
Stock symbol ACCD is outdated, potentially delisted? Maybe it is available on other exchange?
ACCD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $1.30 | -$1.50 | -$0.12 | -$0.10 |
| 2025Q2 | $1.33 | -$0.30 | $0.05 | $0.04 |
| 2025Q1 | $1.41 | -$0.35 | -$0.09 | -$0.12 |
| 2024Q4 | $1.61 | -$0.10 | $0.08 | $0.05 |
| 2024Q3 | $1.31 | -$0.28 | $0.07 | $0.02 |
ACCD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -0.64 |
| 2025Q2 | ? | -3.63 |
| 2025Q1 | ? | -5.01 |
| 2024Q4 | ? | -26.40 |
| 2024Q3 | ? | -7.89 |
ACCD
Price: $7.02
52 week price:
Earnings Per Share: -2.28 USD
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 1.5 million
Market Capitalization: 575.6 million